ISPOR News

Value in Health announced the publication of a themed section examining new approaches to measuring meaningful change for patients with rare diseases.

ISPOR launched its first Interpretive Report on the HARPER Protocol Template, which establishes shared expectations for how researchers should document and communicate the scientific decisions underlying their real-world evidence studies. ISPOR Interpretive Reports are designed to provide everyday language summaries of the Society's reports.

Value in Health announced today the publication of a new commentary that calls for expanding the role of health economics and outcomes research (HEOR) and increasing its impact on real-world decision making.

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Europe 2026 conference. The conference is the leading global event in Europe for health economics and outcomes research (HEOR) and is scheduled for 8-11 November in Vienna, Austria with the theme, “Shaping the Future of Access Through Science and Policy.”

Transparency in research enables the public and decision makers to trust the science that underpins real-world evidence (RWE). ISPOR—The Professional Society for Health Economics and Outcomes Research and the International Society for Pharmacoepidemiology (ISPE) have published a joint RWE Transparency Position Statement.

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a study showing no evidence that the use of quality-adjusted life years (QALYs) inherently disadvantages people with disabilities.

ISPOR announced the launch of its new HEOR Ambassadors website. The site features thought leaders in the field of health economics and outcomes research (HEOR) who can be requested to speak at an event or to members of the media about HEOR-related issues.

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) is proud to announce its Chief Science Officer, Laura Pizzi, PharmD, MPH, has been recognized by NJBIZ as one of its 2026 People to Watch in Healthcare.

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it has released a new white paper, “Achieving Systemic Coherence for Healthcare Decision Making in Europe.”